Accounting intermediate 2

CALCULATOR STANDARD VIEW PRINTER VERSION NEX Problem 16-5 Amy Dyken, controller at Cullumbe diluted earnings per share and the related disclosure for Cullumber's financial statements. Below is selected financial information for the fiscal year ended June 30, 2017 r Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and CULLUMBER PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 Long-term debt Notes payable, 1096 7% convertible bonds payable 10% bonds payable $980,000 5,060,000 5,910,000 $11,950,000 Total long-term debt Shareholders' equity Preferred stock, 6% cumulative, $50 par value, 90,000 shares authorized, 22,500 shares issued and outstanding Common stock, $1 par, 10,100,000 shares authorized, 1,010,000 shares issued and outstanding Additional paid-in capital Retained earnings $1,125,000 1,010,000 4,060,000 6,120,000 $12,315,000 Total shareholders' equity